Detalhe da pesquisa
1.
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation.
Clin Infect Dis
; 67(4): 564-572, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481599
2.
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Clin Infect Dis
; 65(11): 1819-1828, 2017 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020364
3.
Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.
Clin Infect Dis
; 59(4): 473-81, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850801
4.
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Clin Infect Dis
; 57(6): 794-802, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23771985
5.
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.
Bone Marrow Transplant
; 57(1): 23-30, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599284
6.
Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT.
Bone Marrow Transplant
; 56(12): 2929-2933, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34420041
7.
Legionellosis after hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 56(10): 2555-2566, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023859
8.
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Bone Marrow Transplant
; 56(3): 605-613, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004942
9.
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia.
Bone Marrow Transplant
; 55(5): 884-890, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31700137
10.
Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality.
J Infect
; 81(6): 882-894, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186673
11.
Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities.
Bone Marrow Transplant
; 53(9): 1131-1138, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535381
12.
Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study.
Bone Marrow Transplant
; 57(1): 144, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773090
13.
Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Bone Marrow Transplant
; 57(2): 330, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773088
14.
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study.
Bone Marrow Transplant
; 56(3): 692-695, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801318
15.
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
J Clin Oncol
; 34(19): 2212-20, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091716